Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of semaglutide for weight loss in adults with type 1 diabetes and obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

    Recruiting

    3 1 1
    Investigated Drugs:
    Bulgaria Croatia Germany Hungary Poland Portugal +1
  • RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

    Recruiting

    3 1
    Czechia France Germany Hungary Italy Poland +2
  • RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

    Recruiting

    3 1
    Investigated Diseases:
    Belgium Czechia France Germany Hungary Italy +3
  • Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Germany Hungary Poland Spain
  • KAI-9531 in Adults With Obesity or Overweight and Diabetes

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Germany Hungary Poland Spain
  • Zenagamtide for Weight Loss in Adults with Obesity

    Recruiting

    3 1
    Investigated Diseases:
    Belgium Denmark France Germany
  • A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

    Recruiting

    3 1
    Croatia Hungary Italy Romania Slovakia
  • Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Poland
  • A study to evaluate the efficacy and safety of zenagamtide in people with obesity

    Recruiting

    3 1
    Investigated Diseases:
    Belgium Bulgaria Denmark France Germany Italy +2